Delivery Order SPE2DR25D2212-SPE2DR26FB9KL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,217.54 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $31,489 for PREVNAR 20 Syringe 0.5ML on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, with the delivery order specifying...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.94 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency awarded a delivery order valued at $21,268.37 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5mL). This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,522.46 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a firm fixed price structure and an ultimate completion date of September 30, 2025. This non-set-aside award was issued on September 29, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used in federal medical procurement to support military and...
- The Defense Logistics Agency awarded a delivery order valued at $27,354.93 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine critical to military and federal healthcare immunization...
- The Defense Logistics Agency awarded a delivery order valued at $120,771.10 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes. This firm fixed-price, non-set-aside delivery order is scheduled for completion by November 10, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and represents a critical pharmaceutical commodity for military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,971.47 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9KLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,115.24 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used to prevent pneumococcal disease, critical for military and veteran healthcare needs. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen serves as a prime vendor for the DLA Medical Supply Chain, supplying a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency and other federal healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its established capability to meet federal procurement requirements for critical medical commodities including vaccines, specialty medications, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 12/9/25 |